Epistaxis is a condition in which the nose bleeds. It is a common problem that affects people of all ages and can be caused by many factors, such as injury to the nose, nasal polyps, or an allergic reaction. Epistaxis can also be caused by chronic conditions such as high blood pressure or diabetes. The global epistaxis market was valued at USD 1.2 billion in 2018 and is expected to reach USD 2.1 billion by 2030, growing at a CAGR of 5% from 2019 to 2030.
The global epistaxis market has been segmented on the basis of type into vasoconstrictors, anesthetics, antibiotic ointments and cauterizing agents; on the basis of application into pediatric and adult; and on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA). The vasoconstrictors segment accounted for over 50% share in 2018 owing to its wide usage across various applications including pediatric patients with nasal polyps or allergies who are prone to recurrent epistaxis episodes due to their sensitive noses.
Some Of The Growth Factors Of This Market:
- The global population is increasing, which will lead to an increase in the number of people with epistaxis. 2.The aging population will also lead to an increase in the number of people with epistaxis as they are more likely to have chronic nasal and sinus conditions that can cause epistaxis. 3.There is a lack of awareness about the condition, which leads to a delay in diagnosis and treatment, leading to increased incidence rates for this condition 4.There are many new treatments available for this condition that may be more effective than older treatments 5.Epistaxis is often misdiagnosed as something else.
Industry Growth Insights published a new data on “Epistaxis Market”. The research report is titled “Epistaxis Market research by Types (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents), By Applications (Pediatric, Adult), By Players/Companies Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs, King Pharmaceuticals, Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Epistaxis Market Research Report
By Type
Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents
By Application
Pediatric, Adult
By Companies
Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs, King Pharmaceuticals, Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Epistaxis Market Report Segments:
The global Epistaxis market is segmented on the basis of:
Types
Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pediatric, Adult
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smith & Nephew
- Medline
- Bristol-Myers Squibb Pharma Company
- Ciron Drugs
- King Pharmaceuticals, Inc
Highlights of The Epistaxis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vasoconstrictors
- Anesthetics
- Antibiotic Ointments
- Cauterizing Agents
- By Application:
- Pediatric
- Adult
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epistaxis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epistaxis is a medical condition in which the person has a sudden, severe cough.
Some of the key players operating in the epistaxis market are Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs, King Pharmaceuticals, Inc.
The epistaxis market is expected to register a CAGR of 5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Epistaxis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Epistaxis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Epistaxis Market - Supply Chain
4.5. Global Epistaxis Market Forecast
4.5.1. Epistaxis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Epistaxis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Epistaxis Market Absolute $ Opportunity
5. Global Epistaxis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Epistaxis Market Size and Volume Forecast by Type
5.3.1. Vasoconstrictors
5.3.2. Anesthetics
5.3.3. Antibiotic Ointments
5.3.4. Cauterizing Agents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Epistaxis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Epistaxis Market Size and Volume Forecast by Application
6.3.1. Pediatric
6.3.2. Adult
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Epistaxis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Epistaxis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Epistaxis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Epistaxis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Epistaxis Demand Share Forecast, 2019-2026
9. North America Epistaxis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Epistaxis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Epistaxis Market Size and Volume Forecast by Application
9.4.1. Pediatric
9.4.2. Adult
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Epistaxis Market Size and Volume Forecast by Type
9.7.1. Vasoconstrictors
9.7.2. Anesthetics
9.7.3. Antibiotic Ointments
9.7.4. Cauterizing Agents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Epistaxis Demand Share Forecast, 2019-2026
10. Latin America Epistaxis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Epistaxis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Epistaxis Market Size and Volume Forecast by Application
10.4.1. Pediatric
10.4.2. Adult
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Epistaxis Market Size and Volume Forecast by Type
10.7.1. Vasoconstrictors
10.7.2. Anesthetics
10.7.3. Antibiotic Ointments
10.7.4. Cauterizing Agents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Epistaxis Demand Share Forecast, 2019-2026
11. Europe Epistaxis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Epistaxis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Epistaxis Market Size and Volume Forecast by Application
11.4.1. Pediatric
11.4.2. Adult
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Epistaxis Market Size and Volume Forecast by Type
11.7.1. Vasoconstrictors
11.7.2. Anesthetics
11.7.3. Antibiotic Ointments
11.7.4. Cauterizing Agents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Epistaxis Demand Share, 2019-2026
12. Asia Pacific Epistaxis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Epistaxis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Epistaxis Market Size and Volume Forecast by Application
12.4.1. Pediatric
12.4.2. Adult
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Epistaxis Market Size and Volume Forecast by Type
12.7.1. Vasoconstrictors
12.7.2. Anesthetics
12.7.3. Antibiotic Ointments
12.7.4. Cauterizing Agents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Epistaxis Demand Share, 2019-2026
13. Middle East & Africa Epistaxis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Epistaxis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Epistaxis Market Size and Volume Forecast by Application
13.4.1. Pediatric
13.4.2. Adult
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Epistaxis Market Size and Volume Forecast by Type
13.7.1. Vasoconstrictors
13.7.2. Anesthetics
13.7.3. Antibiotic Ointments
13.7.4. Cauterizing Agents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Epistaxis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Epistaxis Market: Market Share Analysis
14.2. Epistaxis Distributors and Customers
14.3. Epistaxis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smith & Nephew
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medline
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb Pharma Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ciron Drugs
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. King Pharmaceuticals, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
